“Real world” eligibility for aducanumab: A Podcast with Tim Anderson and Marco Canevelli
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer's disease, but…
The FDA label for the amyloid antibody aducanumab (Aduhelm) started off exceedingly broad, basically including anyone with Alzheimer's disease, but…
Today’s podcast is on academic life hacks, those tips and tricks we have seen and developed over the years to…
On June 7th, 2021 FDA approved the amyloid beta-directed antibody aducanumab (Aduhelm) for the Treatment of Alzheimers. This approval of…
Cannabis use by older adults has increased substantially over the last decade, a trend that has paralleled the legalization of…
In a new study in JAGS, Matthew Growdon found that the average number of medications people with dementia took in…
On the one hand, every year we are fortunate to have new medications that help older adults and people living…
"Tell me about the problems you have with your medications." A simple open-ended question that is probably rarely asked, but…
Before we get into this week's topic, would you please take 1 MINUTE to complete this GeriPal survey! It will…
Tramadol. Is it just a misunderstood opioid that is finally seeing its well deserved day in the sun, or is…
I recently had the fortune to hear Dr. Kathy Foley talk about palliative care and the opioid epidemic. First, let…